The results from an international study on nivolumab, published in the New England Journal of Medicine, suggest a paradigm shift in the standard of care for previously treated lung cancer patients. / read more /
Researchers in the US, Japan, and China are recognized for developing therapies to combat river blindness, lymphatic filariasis, and malaria. / read more /
advertisement
Subscribe
Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.
How does your compensation and job satisfaction compare with peers around the world? The editors of Pharmaceutical Technology Europe invite you to participate in the annual employment survey.
Probiodrug has signed an agreement with Rentschler Biotechnologie GmbH for the development and production of PBD-C06, a pGlu-Abeta-specific monoclonal antibody, as treatment for patients with Alzheimer’s disease. / read more /
3M and Impel will collaborate to develop and commercialize Impel’s Precision Olfactory Delivery technology for enhanced central nervous system drug delivery. / read more /
Thorough process knowledge is needed to develop process control strategies and select process equipment configuration for continuous manufacturing. / read more /
Experts from Dow Pharma & Food Solutions discuss the versatility of solid dispersions in solubility enhancement and the importance of pairing the API to the optimal polymer. / read more /
CAPMUL® — Where Formulation Begins™
ABITEC's CAPMUL bioavailability enhancers are medium-chain mono- and di-glycerides and propylene glycol esters. These functional lipid excipients act as solubilizers and emulsifiers in oral, topical, transdermal, and parenteral drug delivery systems.
/ Read More /
The Life Sciences Guidebook: Selecting, Implementing, and Using FDA Compliance Software Solutions
In a market where high-demand causes organizations to seek software systems that will fit into their complex business infrastructure, the pressure to find the right system often causes angst to many. Learn some key elements to spotting a good FDA Compliance solution, techniques for achieving Good Manufacturing Practice (GMP) Compliance, and how to ensure that Quality and Compliance are met in the Life Science industry. / Download Guidebook Now /
Gerresheimer Group
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. / Read More /
Bohle Coating – Bohle Film Coater BFC
The BFC is the high-end version of the Bohle coater designed specifically for high speed, problem-free coating, providing unparalleled tablet uniformity and efficiencies. A high containment execution is also available. / Read More /
The Swiss Knife of analytics
Shimadzu has released its new Nexera UC unified chromatography system. It is the world’s first-ever unified and fully automated instrument combining supercritical fluid extraction (SFE) with supercritical fluid chromatography (SFC). / Read More /
High Potency APIs
Umicore is one of the largest producers of platinum APIs for anti-cancer treatment. We pride ourselves in having decades of experience in platinum group metals chemistry and high potency APIs. / Read More /
Cleanroom Documentation Systems Introducing VAI’s Cleanroom Documentation Systems, the Core2Print, Core2Write, and CleanPrint 10 that address the problem of documentation materials that shed fibers or particulates in aseptic GMP operations.
/ Read More /
Meet 32,000 Pharma Professionals @South Asia's largest Pharma Expo
1st – 3rd December 2015 Bombay Convention & Exhibition Centre, Mumbai, India / Learn more /
In this webcast, experts will review the sources of contamination, regulations and guidance documents on the control of potential contaminants in raw materials, and best practices to guard against the introduction of contaminants in the manufacturing process. The challenges of detecting contaminants, including mycoplasma, assay development, and testing practices will be discussed. Sponsored by SGS Life Science Services
On Demand
This webinar, led by Milton Boyer, senior vice-president of drug product manufacturing at AMRI, will review and challenge the changing paradigms in the CMO/drug sponsor relationship. It is clear that both CMOs and drug sponsors are being held responsible for the actions of the other. Responsibilities once thought to be clearly defined are changing, with new guidance and expectations revealed in 483s and FDA warning letters. Sponsored by AMRI
A compilation of informative, useful articles designed to help you meet the challenges of process analytical technology, be more efficient in testing, reduce over-processing, enhance consistency, and minimize rejects. / Click here /
